SUMC in the News (08/25/06)
Print media coverage
Sacramento Bee, 08/25/06
Patent foes get a break in fight
This article discusses how a proposed new method of generating human embryonic
cells raises intellectual property issues that could affect California. Hank
Greely, with the Stanford Center for Biomedical Ethics, is quoted here. Iving
Weissman, the Virginia and DK Ludwig Professor for Clinical Investigation and
director of the Stanford Institute for Stem Cell Biology and Regenerative
Medicine, provides comment on the alternative method in an article on
Sci-TechToday.com.
San Francisco Chronicle, 08/25/06
Plan B approval ends a 3-year fight
The FDA on Thursday approved Plan B - also known as the morning-after pill -for
sale without a prescription to women age 18 and older. Kay Daniels, associate professor of obstetrics and gynecology, provides comment in this article.
New York Times, 08/24/06
White House says new stem cell method "encouraging"
This article discusses how the White House said it was encouraged by a newly
published method of generating human embryonic stem cells without destroying the
embryo. William Hurlbut, consulting professor of neurology, is quoted in this
Reuters article, which also appears in the Boston Globe.
Forbes.com, 08/24/06
Denial and death on Mount Everest
This HealthDay article discusses how altitude sickness is a significant threat
to those who climb Mount Everest. Ken Zafren, clinical assistant professor of
emergency medicine and associate medical director of the Himalayan Rescue
Association, is quoted here.
Broadcast media coverage
KGO-TV, 08/24/06
Stanford researchers are trying a new therapy to provide relief for people
suffering with rheumatoid arthritis. Mark Genovese, associate professor of
medicine, was interviewed during this segment.
.
Office of Communication